Dai Hongwei, a professor at the Central University of Finance and Economics: We must give full play to the advantages of central cities in scientific and technological innovation. Dai Hongwei, a professor and doctoral supervisor at the Central University of Finance and Economics, believes that it is necessary to actively cultivate new growth poles for innovation to drive regional economic growth. We must give full play to the radiation-driven role of central cities, especially in the context of innovation-driven development. We must pay attention to giving full play to the advantages of central cities in scientific and technological innovation, driving the development of surrounding areas, accelerating the development of new quality productivity, and at the same time give full play to the important role of urban agglomerations in promoting collaborative innovation and group development. (SSE)Market news: Hungary and Bulgaria find solutions for Russian natural gas transportation.Governor of Poland's central bank: Poland will continue to achieve the CPI target.
Canada recorded a monthly wholesale sales rate of 1% in October, the largest increase since April 2024. Canada recorded a monthly wholesale sales rate of 1% in October, with an expected 0.5% and a previous value of 0.80%. Canada's annual wholesale sales rate in October was 1.7%, and the previous value was -0.4%. Canada's annual wholesale inventory rate in October was -1%, and the previous value was 0.7%. The monthly rate of wholesale inventory in Canada in October was 0.9%, and the previous value was 0.2%. The monthly inventory rate of manufacturing industry in Canada in October was 0.2%, and the previous value was -0.4%. The monthly rate of new manufacturing orders in Canada in October was -0.9%, and the previous value was 3.9%. The monthly rate of unfinished orders in Canada's manufacturing industry in October was -0.2%, and the previous value was 1.6%. Canada's capacity utilization rate in the third quarter was 79.3%, with an expected 78.9% and a previous value of 79.10%. Canada's manufacturing inventory shipment ratio in October was 1.69%, and the previous value was 1.74%.Nearly 30 listed companies announced after-hours that their products would be selected, and the tenth batch of centralized drug procurement (centralized drug procurement) organized by the state was opened in Shanghai yesterday. According to incomplete statistics, as of press time, it includes Fuyuan Pharmaceutical, Yifan Pharmaceutical, ST Tiansheng, Hokuriku Pharmaceutical, Haizheng Pharmaceutical, Zhongheng Group, Yuandong Bio, Kelun Pharmaceutical, China Resources Shuanghe, Sinopharm Modern, Lingkang Pharmaceutical, Xuantai Pharmaceutical, Jiuzhou Pharmaceutical, Kang Enbei, Laimei Pharmaceutical, Kanghong Pharmaceutical, Huasen Pharmaceutical, Borui Pharmaceutical, Xianzeng Pharmaceutical. Among them, Kelun Pharmaceutical announced that 12 kinds of drugs, such as sodium acetate Ringer injection, sodium bicarbonate Ringer injection and gliclazide tablets, were to be selected.Market News: Trump's assistant asked Trump if it was possible to abolish the Federal Deposit Insurance Corporation (FDIC).
BMO raised the target price of Chevron from $170 to $175.CGNPC Delingha Photothermal Storage Integration Project was partially connected to the grid for power generation. The reporter learned from China Guangdong Nuclear Power Group Co., Ltd. that on December 13th, 800,000 kilowatts of photovoltaic power generation in CGNPC Delingha 1 million kilowatts Photothermal Storage Integration Project was partially connected to the grid for power generation. (Xinhua News Agency)Huangshan Capsule: It is planned to distribute a cash dividend of 0.27 yuan for every 10 shares. Huangshan Capsule announced that the company held the board of directors and the board of supervisors on December 13, 2024, and reviewed and approved the profit distribution plan for the first three quarters of 2024. According to the plan, the company plans to distribute a cash dividend of RMB27 to all shareholders for every 10 shares based on the existing total share capital of 299 million shares, with a total cash dividend of RMB8,075,700. This profit distribution will not send bonus shares, and capital reserve will not be converted into share capital.